Literature DB >> 21474672

Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality.

Yaping Sun1, Sooryanarayana Varambally, Christopher A Maher, Qi Cao, Peter Chockley, Tomomi Toubai, Chelsea Malter, Evelyn Nieves, Isao Tawara, Yongqing Wang, Peter A Ward, Arul Chinnaiyan, Pavan Reddy.   

Abstract

While miRNAs are increasingly linked to various immune responses, whether they can be targeted for regulating in vivo inflammatory processes such as endotoxin-induced Gram-negative sepsis is not known. Production of cytokines by the dendritic cells (DCs) plays a critical role in response to endotoxin, lipopolysaccharide (LPS). We profiled the miRNA and mRNA of CD11c⁺ DCs in an unbiased manner and found that at baseline, miR-142-3p was among the most highly expressed endogenous miRs while IL-6 was among the most highly expressed mRNA after LPS stimulation. Multiple computational algorithms predicted the IL-6 3' untranslated region (UTR) to be a target of miR-142-3p. Studies using luciferase reporters carrying wild-type (WT) and mutant IL-6 3'UTR confirmed IL-6 as a target for miR-142-3p. In vitro knockdown and overexpression studies demonstrated a critical and specific role for miR142-3p in regulating IL-6 production by the DCs after LPS stimulation. Importantly, treatment of only WT but not the IL-6-deficient (IL-6(⁻/⁻)) mice with locked nucleic acid (LNA)-modified phosphorothioate oligonucleotide complementary to miR 142-3p reduced endotoxin-induced mortality. These results demonstrate a critical role for miR-142-3p in regulating DC responses to LPS and provide proof of concept for targeting miRs as a novel strategy for treatment of endotoxin-induced mortality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474672      PMCID: PMC3122940          DOI: 10.1182/blood-2010-12-325647

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  Apoptosis and caspases regulate death and inflammation in sepsis.

Authors:  Richard S Hotchkiss; Donald W Nicholson
Journal:  Nat Rev Immunol       Date:  2006-10-13       Impact factor: 53.106

2.  An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

Authors:  Dimitrios Iliopoulos; Heather A Hirsch; Kevin Struhl
Journal:  Cell       Date:  2009-10-29       Impact factor: 41.582

Review 3.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

4.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

Authors:  Z Xing; J Gauldie; G Cox; H Baumann; M Jordana; X F Lei; M K Achong
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

Review 5.  IL-6 and APPs: anti-inflammatory and immunosuppressive mediators.

Authors:  H Tilg; C A Dinarello; J W Mier
Journal:  Immunol Today       Date:  1997-09

6.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

7.  Involvement of microRNA in AU-rich element-mediated mRNA instability.

Authors:  Qing Jing; Shuang Huang; Sabine Guth; Tyler Zarubin; Andrea Motoyama; Jianming Chen; Franco Di Padova; Sheng-Cai Lin; Hermann Gram; Jiahuai Han
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

8.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

9.  Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.

Authors:  H Tilg; E Trehu; M B Atkins; C A Dinarello; J W Mier
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

10.  Defective inflammatory response in interleukin 6-deficient mice.

Authors:  E Fattori; M Cappelletti; P Costa; C Sellitto; L Cantoni; M Carelli; R Faggioni; G Fantuzzi; P Ghezzi; V Poli
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  68 in total

Review 1.  Functional regulation of monocyte-derived dendritic cells by microRNAs.

Authors:  Yifan Zhan; Li Wu
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

Review 2.  microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis.

Authors:  Martin Busch; Alma Zernecke
Journal:  J Mol Med (Berl)       Date:  2012-02-04       Impact factor: 4.599

3.  Aberrant elevated microRNA-146a in dendritic cells (DC) induced by human pancreatic cancer cell line BxPC-3-conditioned medium inhibits DC maturation and activation.

Authors:  Jian Du; Jingwen Wang; Guang Tan; Zhengang Cai; Lu Zhang; Bo Tang; Zhongyu Wang
Journal:  Med Oncol       Date:  2012-02-07       Impact factor: 3.064

4.  Intrinsic transgene immunogenicity gears CD8(+) T-cell priming after rAAV-mediated muscle gene transfer.

Authors:  Maxime Carpentier; Stéphanie Lorain; Pascal Chappert; Mélanie Lalfer; Romain Hardet; Dominique Urbain; Cécile Peccate; Sahil Adriouch; Luis Garcia; Jean Davoust; David-Alexandre Gross
Journal:  Mol Ther       Date:  2014-12-10       Impact factor: 11.454

5.  Pigmy MicroRNA: surveillance cops in Therapies kingdom.

Authors:  Utpal Bhadra; Pradipta Patra; Jagamohan Chhatai; Manika Pal-Bhadra
Journal:  Mol Med       Date:  2016-09-28       Impact factor: 6.354

Review 6.  MicroRNAs in normal and psoriatic skin.

Authors:  Jing Xia; Weixiong Zhang
Journal:  Physiol Genomics       Date:  2013-12-10       Impact factor: 3.107

7.  Allogeneic T cell responses are regulated by a specific miRNA-mRNA network.

Authors:  Yaping Sun; Isao Tawara; Meng Zhao; Zhaohui S Qin; Tomomi Toubai; Nathan Mathewson; Hiroya Tamaki; Evelyn Nieves; Arul M Chinnaiyan; Pavan Reddy
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

Review 8.  Next generation treatment of acute graft-versus-host disease.

Authors:  J Magenau; P Reddy
Journal:  Leukemia       Date:  2014-06-18       Impact factor: 11.528

9.  Expression profile of microRNAs following bone marrow-derived mesenchymal stem cell treatment in lipopolysaccharide-induced acute lung injury.

Authors:  Joonhong Park; Sikyoung Jeong; Kicheol Park; Keumjin Yang; Soyoung Shin
Journal:  Exp Ther Med       Date:  2018-05-02       Impact factor: 2.447

10.  MicroRNA-142-3p Inhibits Chondrocyte Apoptosis and Inflammation in Osteoarthritis by Targeting HMGB1.

Authors:  Xiuqin Wang; Yanqing Guo; Chunyan Wang; Hong Yu; Xiuxiang Yu; Hongbo Yu
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.